BCI Marketplace
Transcranial Magnetic Stimulation trials

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

RecruitingNCT07324070Phase: NAStarted 2026-01-05

Summary

The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Inclusion Criteria: * Age equal to 18 or higher * MADRS (Montgomery-Asberg Depression Scale) qual or higher than 20 * Major depressive disorder according to ICD 10 Exclusion Criteria: * Other axis 1 disorder (for example schizofrenia, addiction, etc.) * No dementia * ECT in the last 3 months * TM

Locations

General University Hospital, Psychiatry department
Prague, Czech, Czechia

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →